guest ::
| Home > Publications Database > A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice. > print |
| Home > Publications Database > A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice. > print |
| 001 | 138219 | ||
| 005 | 20240321220408.0 | ||
| 024 | 7 | _ | |a 10.1016/j.nbd.2015.05.015 |2 doi |
| 024 | 7 | _ | |a pmid:26049140 |2 pmid |
| 024 | 7 | _ | |a 0969-9961 |2 ISSN |
| 024 | 7 | _ | |a 1095-953X |2 ISSN |
| 024 | 7 | _ | |a altmetric:4108918 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-04541 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Zhang, Jingzhong |b 0 |
| 245 | _ | _ | |a A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice. |
| 260 | _ | _ | |a Orlando, Fla. |c 2015 |b Academic Press |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2015-10-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1589442774_3785 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The protracted and age-dependent degeneration of dopamine (DA)-producing neurons of the Substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in the mammalian midbrain is a hallmark of human Parkinson's Disease (PD) and of certain genetic mouse models of PD, such as mice heterozygous for the homeodomain transcription factor Engrailed 1 (En1(+/-) mice). Neurotoxin-based animal models of PD, in contrast, are characterized by the fast and partly reversible degeneration of the SNc and VTA DA neurons. The secreted protein WNT1 was previously shown to be strongly induced in the neurotoxin-injured adult ventral midbrain (VM), and to protect the SNc and VTA DA neurons from cell death in this context. We demonstrate here that the sustained and ectopic expression of Wnt1 in the SNc and VTA DA neurons of En1(+/Wnt1) mice also protected these genetically affected En1 heterozygote (En1(+/-)) neurons from their premature degeneration in the adult mouse VM. We identified a developmental gene cascade that is up-regulated in the adult En1(+/Wnt1) VM, including the direct WNT1/β-catenin signaling targets Lef1, Lmx1a, Fgf20 and Dkk3, as well as the indirect targets Pitx3 (activated by LMX1A) and Bdnf (activated by PITX3). We also show that the secreted neurotrophin BDNF and the secreted WNT modulator DKK3, but not the secreted growth factor FGF20, increased the survival of En1 mutant dopaminergic neurons in vitro. The WNT1-mediated signaling pathway and its downstream targets BDNF and DKK3 might thus provide a useful means to treat certain genetic and environmental (neurotoxic) forms of human PD. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-10-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Brain-Derived Neurotrophic Factor |2 NLM Chemicals |
| 650 | _ | 7 | |a Dkk3 protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a En1 protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a Homeodomain Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Intercellular Signaling Peptides and Proteins |2 NLM Chemicals |
| 650 | _ | 7 | |a Wnt1 Protein |2 NLM Chemicals |
| 650 | _ | 2 | |a Adaptor Proteins, Signal Transducing |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Brain-Derived Neurotrophic Factor: genetics |2 MeSH |
| 650 | _ | 2 | |a Brain-Derived Neurotrophic Factor: metabolism |2 MeSH |
| 650 | _ | 2 | |a Cell Differentiation: genetics |2 MeSH |
| 650 | _ | 2 | |a Dopaminergic Neurons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Dopaminergic Neurons: pathology |2 MeSH |
| 650 | _ | 2 | |a Gene Expression Regulation, Developmental |2 MeSH |
| 650 | _ | 2 | |a Homeodomain Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a Intercellular Signaling Peptides and Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a Intercellular Signaling Peptides and Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Mice, Transgenic |2 MeSH |
| 650 | _ | 2 | |a Nerve Degeneration: genetics |2 MeSH |
| 650 | _ | 2 | |a Nerve Degeneration: metabolism |2 MeSH |
| 650 | _ | 2 | |a Nerve Degeneration: pathology |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: metabolism |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: pathology |2 MeSH |
| 650 | _ | 2 | |a Signal Transduction: genetics |2 MeSH |
| 650 | _ | 2 | |a Substantia Nigra: metabolism |2 MeSH |
| 650 | _ | 2 | |a Substantia Nigra: pathology |2 MeSH |
| 650 | _ | 2 | |a Up-Regulation |2 MeSH |
| 650 | _ | 2 | |a Ventral Tegmental Area: metabolism |2 MeSH |
| 650 | _ | 2 | |a Ventral Tegmental Area: pathology |2 MeSH |
| 650 | _ | 2 | |a Wnt1 Protein: metabolism |2 MeSH |
| 700 | 1 | _ | |a Götz, Sebastian |b 1 |
| 700 | 1 | _ | |a Vogt-Weisenhorn, Daniela |0 P:(DE-2719)9000331 |b 2 |u dzne |
| 700 | 1 | _ | |a Simeone, Antonio |b 3 |
| 700 | 1 | _ | |a Wurst, Wolfgang |0 P:(DE-2719)2000028 |b 4 |e Corresponding author |u dzne |
| 700 | 1 | _ | |a Prakash, Nilima |0 P:(DE-HGF)0 |b 5 |
| 773 | 1 | 8 | |a 10.1016/j.nbd.2015.05.015 |b : Elsevier BV, 2015-10-01 |p 32-45 |3 journal-article |2 Crossref |t Neurobiology of Disease |v 82 |y 2015 |x 0969-9961 |
| 773 | _ | _ | |a 10.1016/j.nbd.2015.05.015 |g Vol. 82, p. 32 - 45 |0 PERI:(DE-600)1471408-5 |q 82<32 - 45 |p 32-45 |t Neurobiology of disease |v 82 |y 2015 |x 0969-9961 |
| 909 | C | O | |o oai:pub.dzne.de:138219 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)9000331 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2000028 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |2 G:(DE-HGF)POF3-300 |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEUROBIOL DIS : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b NEUROBIOL DIS : 2017 |
| 920 | 1 | _ | |0 I:(DE-2719)5000050 |k Ext HZM |l Ext HZM |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1140001 |k AG Wurst |l Genome Engineering |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000050 |
| 980 | _ | _ | |a I:(DE-2719)1140001 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|